The methods recently developed for predicting before birth infants potentially at risk of neonatal respiratory distress syndrome (RDS) undoubtedly represent a major advance in obstetric care. When positive results are obtained these methods enable the obstetrician to terminate a complicated pregnancy well before term, safe in the knowledge that the infant will not develop RDS; negative results warn that the fetal lungs are not mature and that delivery should be delayed even if the pregnancy may appear to be at term. This is particularly important since the use of oral contraception before pregnancy has reduced the accuracy of the menstrual data for calculating gestational age.
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Methods
All methods developed for assessing fetal pulmonary maturity in utero depend on the fact that, to maintain normal respiration, the alveoli of the neonatal lungs must have an adequate lining of surfactant. Since fetal pulmonary fluid contributes to the formation of amniotic fluid (Ross 1963) , the alveolar surfactant concentration of the fetus in utero is therefore likely to be reflected in the amniotic fluid surfactant concentration, and this in turn should predict the quality of respiration in the neonate. Amniotic fluid lecithin assay: The main component of surfactant is lecithin, and Bhagwanani et al. (1972a) developed a biochemical method for measuring the amniotic fluid lecithin concentration. The surge in concentration which 'Present address: Nuffield Department ofObstetrics & Gynecology, John Radcliffe Hospital, Headington, Oxford occurs at 34-36 weeks indicates fetal pulmonary maturation and it was shown that an amniotic fluid lecithin level of about 3.5 mg/100 ml was critical: if it was above that level, RDS would not occur, but if it was below, RDS was almost invariable. The method was prolonged and tedious, involving extraction of amniotic fluid lipids with chloroform and methanol, thin layer chromatography to identify the lecithin band, and finally quantitation of the eluted lecithin as lecithin phosphorus.
Subsequently, Bhagwanani et al. (1972b) described a quicker method of similar precision, but we found that with a little experience, the size of the lecithin band on the thin layer plate associated with a low level (< 2 mg/100 ml) or a high level (> 5 mg/100 ml) could readily be differentiated by simple observation. In clinical practice, therefore, 70 % ofcases could be assessed within 2 hours, and only intermediate levels had to be quantitated exactly.
Amniotic fluid lecithin/sphingomyelin ratio: Prior to the Cardiff work, Gluck et al. (1971) were the first to demonstrate the practicability of assessing fetal pulmonary maturity in utero, having developed a semiquantitative method for measuring the lecithin/sphingomyelin (L/S) ratio. The value of the L/S ratio depends on the fact that the concentration of lecithin in amniotic fluid is less than sphingomyelin up to about 35-36 weeks, at which time a surge i'n the lecithin concentration increases the L/S ratio, indicating fetal pulmonary maturation.
The original method proved difficult to replicate in several laboratories, but modifications by Borer et al. (1971) provided a more convenient method. Briefly, this method involves extraction of amniotic fluid lipids with chloroform and ethanol, thin layer chromatography to separate lecithin and sphingomyelin, and calculation of the L/S ratio by comparing the area of lecithin and sphingomyelin 'spots'. Gluck & Kulovich (1973) postulated that an L/S ratio of 2.0 or more indicates mature fetal lungs, with no risk of RDS, while infants with an L/S ratio of less than 2.0 have some clinical RDS, the lower the L/S ratio, the more severe the RDS.
The 'shake' test: Clements et al. (1972) reported the development and use of a quick and simple test for amniotic fluid surfactant based on the stability of bubbles formed by shaking amniotic fluid treated with ethanol. The test depends on the ability of the pulmonary surfactant in amniotic fluid to maintain a stable foam after shaking. Other substances in amniotic fluid can reduce surface tension and interfere with the result, but are excluded from the surface films by the nonfoaming competitive surfactant ethanol.
Varying amounts of amniotic fluid (1 ml undiluted and 0.75, 0.50, 0.25 and 0.20 ml made up to 1 ml with normal saline) are each vigorously shaken with 1 ml 95% ethanol for 15 seconds. The presence of an unbroken ring of bubbles at the meniscus after 15 minutes in the first three tubes is interpreted as positive, indicating mature fetal lungs. If the ring of bubbles is incomplete in the first tube the test is negative, indicating immature lungs, and if complete in only the first, or in the first and second, the test is considered intermediate. Clements and his colleagues reported excellent prediction results with this 'shake' test in clinical practice.
Results
This paper gives our results with these three tests in clinical practice in Cardiff. Including only tests performed on mothers within 48 hours of delivery, we have measured amniotic fluid lecithin in 196, L/S ratio in 171 and bubble stability in ethanol in 95. Some of the results have been published previously (Bhagwanani et al. 1972a (Bhagwanani et al. , 1972b (Bhagwanani et al. , 1973a , but some additional material has been included and our experience with the use of the L/S ratio awaits publication (Bhagwanani et al. 1974, in preparation) .
Briefly, we find that positive results with any of the tests reliably exclude the possibility of RDS; i.e. if, within the 48 hours before delivery, the amniotic lecithin level is 3.5 mg/100 ml or more, the L/S ratio 2 or more, or the 'shake' test positive, the risk of RDS developing in the neonate is negligible.
At the other end of the scale erroneous results can be obtained and, unfortunately in our experience, the simpler the test, the greater the possibility of false negative results. With the 'shake' test, for example, 32 tests gave negative results and 19 were intermediate but over 80% of the infants had normal respiration. With L/S ratios below 1.5, the risk of RDS was high, although not certain (77 %); but with intermediate ratios (1.5 to < 2) only 23 Y. of neonates developed RDS. By contrast, in cases where amniotic fluid lecithin concentration was below 3.5 mg/100 ml, 23 out of 24 infants developed RDS. We also found that total phospholipid concentration was low (<9 mg/100 ml) in all cases where the infant developed RDS, but found that levels could also be low when neonatal respiration was normal, so that the accuracy of total phospholipid assay for predicting RDS was only 60 %.
The problem with the false negative result is that the potential risk of RDS cannot be ignored by the clinician, who may accordingly postpone delivery of a fetus in jeopardy, with the possible risk of intrauterine death.
On the other hand, speed and convenience in testing is of importance to the clinician. Assay of amniotic fluid lecithin, even by the quicker method reported by Bhagwanani et al. (1972b) , is rather laborious and can only be performed in the laboratory. By comparison, the 'shake' test can be performed almost at the bedside, and certainly in a ward laboratory. When a test is required only to confirm fetal pulmonary maturity before elective delivery at term, the 'shake' test seems suitable, but adequate back-up facilities are required, either an assay of amniotic fluid lecithin or of the L/S ratio, to confirm a negative 'shake' test. We know of workers whose experience with the 'shake' test coincides with our own, and also of others who find a very high proportion of positive results. These differences illustrate the problem of interpreting results which depend on the opinion of the observer. Of the two more complicated tests, we prefer assay of amniotic fluid lecithin, as its quantitation and predictive value seem so reliable and our findings have been confirmed by Nelson (1972) . Nevertheless, the L/S ratio is quick and reliable when the results are above 2 or below 1.5, and is independent of gross variations in amniotic fluid voluime, a factor which could at least theoretically influence the concentration of lecithin in amniotic fluid, although this has not so far proved a problem in our experience. Although better methods for testing will doubtless be developed in the future, the tests now available for assessing fetal pulmonary maturity in utero represent a great advance over the methods used previously to assess the duration of pregnancy, for they provide a reliable prediction of the most feared complication of premature deliveryneonatal respiratory distressand give a new insight into the intrauterine development of the fetus. While results from these tests cannot be expected to prevent RDS altogether, they should at least exclude unexpected prematurity from elective delivery. Using the Gregory Box Gregory et al. (1971) in San Francisco reported treating 20 infants with severe respiratory distress syndrome (RDS) with continuous positive airway pressure (CPAP). Up to 12 mmHg pressure was delivered by endotracheal tube to 18 infants and via a head box to the remaining 2. Sixteen of the 20 infants survived, including 7 out of 10 weighing less than 1500 g at birth. In October 1971 we adopted this form of treatment, and, in particular, the head chamber or Gregory box. Our early results have been reported elsewhere (Dunn et al. 1971 elsewhere (Dunn et al. , 1972 elsewhere (Dunn et al. , 1974 . This paper deals with our first 15 months experience.
Management ofRDS
Infants exhibiting signs of inspiratory retraction, expiratory grunting, cedema and poor alveolar air entry soon after birth, with or without tachypnoea and cyanosis, were initially given warmth to maintain a normal body temperature, oxygen as required to 35 %, and carefully observed with minimal handling. Many such infants improved during the first few hours of life. They were classed as 'transitory RDS' and were not included in our RDS statistics. If, however, at the age of 4-6 hours the signs had not improved (or the infant had already required respiratory assistance) and characteristic radiological changes were present, a diagnosis of RDS was confirmed and the following standard treatment commenced.
Umbilical catheters were passed until their tips lay respectively in the inferior vena cava and lower aorta. Then, 5 % dextrose/5 % fructose solution was infused at a rate of 3 ml/kg per hour, increasing to 4 ml/kg per hour at 24 hours; oral feeding was rarely introduced before 49 hours. Monitoring of arterial blood gases and acid-base status was undertaken every 3-6 hours. The ambient oxygen concentration (F1o2) was adjusted
